# FDA recall D-0066-2021

> **Jubilant Cadista Pharmaceuticals, Inc.** · Class III · drug recall initiated 2020-10-26.

## Product

Olanzapine Orally Disintegrating Tablets, 5 mg, 30 count (3x10 unit dose) blister pack, Rx only, Manufactured by: Jubilant Generics, Ltd., Roorkee, India, Marketed by: Jubilant Cardista Pharmaceuticals, Inc., Salisbury, MD  NDC 59746-0306-32

## Reason for recall

Subpotent

## Distribution

Product was distributed nationwide

## Key facts

- **Recall number:** D-0066-2021
- **Recalling firm:** Jubilant Cadista Pharmaceuticals, Inc.
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2020-10-26
- **Report date:** 2020-11-11
- **Termination date:** 2021-08-11

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Salisbury, MD, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0066-2021

## Citation

> AI Analytics. FDA recall D-0066-2021. Retrieved 2026-07-26 from https://api.ai-analytics.org/recall/D-0066-2021. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*